Publications

Interpharma members are constantly working to develop new research methods and to minimise the number of laboratory animals. However, animal experiments remain essential for researching ubiquitous diseases such as cancer, multiple sclerosis and Alzheimer’s disease, and in developing new treatments. It is therefore important that pharmaceutical companies give top priority to responsible animal use and actively implement the 10-point Animal Welfare Charter adopted by member companies of Interpharma in 2010.

Our Health Panorama offers a compact overview of the key facts, figures and developments related to the healthcare system, the pharmaceuticals market and Switzerland’s position as a pharma hub.